Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype

BACKGROUND: Antibodies against myelin oligodendrocyte glycoprotein (MOG) have been identified in a subgroup of pediatric patients with inflammatory demyelinating disease of the central nervous system (CNS) and in some patients with neuromyelitis optica spectrum disorder (NMOSD). The aim of this stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Pröbstel, Anne-Katrin, Rudolf, Gabrielle, Dornmair, Klaus, Collongues, Nicolas, Chanson, Jean-Baptiste, Sanderson, Nicholas SR, Lindberg, Raija LP, Kappos, Ludwig, de Seze, Jérôme, Derfuss, Tobias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359547/
https://www.ncbi.nlm.nih.gov/pubmed/25889963
http://dx.doi.org/10.1186/s12974-015-0256-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359547/
https://www.ncbi.nlm.nih.gov/pubmed/25889963
http://dx.doi.org/10.1186/s12974-015-0256-1

Ejemplares similares